Jonas Boström is a Principal Scientist at AstraZeneca in the CVMD iMed. He obtained a M.S. in Chemistry at the University of Gothenburg in 1996 and a Ph.D. in Computational Medicinal Chemistry in 2000 at the Royal Danish School of Pharmacy (Copenhagen, Denmark). After a short spell at H. Lundbeck A/S he joined AstraZeneca. Jonas has gained knowledge of most aspects of preclinical drug discovery from his 15 years in the pharmaceutical industry. Among other things, this has resulted in 15 patent specifications, including 10 candidate drugs. Current research interests include combining new technology, informatics, and science in innovative ways to tackle the challenging tasks in drug discovery, as well as trying to distinguish science facts from science fiction.
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.